Clinical Trials Browser

Phase 2 × NIH × Metformin × Clear all

NCT02581137 2026-04-13

Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion

Phase 2 Active not recruiting

26 enrolled 10 charts

Erythroplasia, Hyperplasia, Leukoplakia, Oral, Mouth Neoplasms

NCT01312467 2019-03-05

Trial of Metformin for Colorectal Cancer Risk Reduction for History of Colorectal Adenomas and Elevated BMI

Phase 2 Completed

45 enrolled 7 charts

GastrointestinalOther

Obesity, Colorectal Neoplasms, Adenomatous Polyps

NCT01433913 2018-01-10

Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery

Phase 2 Completed

20 enrolled 17 charts

Prostatic Neoplasms

NCT01447927 2014-07-21

Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagus

Phase 2 Completed

93 enrolled 10 charts

Gastrointestinal

Barrett Esophagus, Esophageal Neoplasms